Seres Therapeutics (MCRB) Current Deferred Revenue (2016 - 2024)
Seres Therapeutics' Current Deferred Revenue came in at $7.92 million for Q2 2024, up 181.2% from $2.82 million a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Current Deferred Revenue (2016 - 2024) Analysis & Trends
At the end of FY2023, Seres Therapeutics' Current Deferred Revenue was $7.73 million, up 81.5% from FY2022.
- Current Deferred Revenue carries a five-year compound annual growth rate of -17.7% (FY2018 to FY2023).
- Going back by year, Current Deferred Revenue was $4.26 million in FY2022 (-74.7%), $16.82 million in FY2021 (-25.6%), $22.6 million in FY2020 (+7.8%) and $20.96 million in FY2019 (+2.6%).
- The five-year range for quarterly Current Deferred Revenue is $2.38 million (Q1 2023) to $22.6 million (Q4 2020).
- Year-over-year, Current Deferred Revenue has increased for four consecutive quarters, with growth averaging 35.4% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q1 2024 (growth of 241.3%), and the weakest in Q1 2023 (a decline of 88.4%).
- Business Quant data shows MCRB's Current Deferred Revenue at $8.11 million (Q1 2024), $7.73 million (Q4 2023) and $9.47 million (Q3 2023) in the three quarters before Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Seres Therapeutics | 22.42 Mn | -116.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 7.92 Mn |
| Mar 31, 2024 | 8.11 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 9.47 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 4.26 Mn |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 11.10 Mn |
| Mar 31, 2022 | 20.44 Mn |
| Dec 31, 2021 | 16.82 Mn |
| Sep 30, 2021 | 21.62 Mn |
| Jun 30, 2021 | 19.83 Mn |
| Mar 31, 2021 | 21.24 Mn |
| Dec 31, 2020 | 22.60 Mn |
| Sep 30, 2020 | 16.52 Mn |
| Jun 30, 2020 | 19.04 Mn |
| Mar 31, 2020 | 19.97 Mn |
| Dec 31, 2019 | 20.96 Mn |
| Sep 30, 2019 | 21.14 Mn |
API Access
Seres Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();